Upstream Bio, Inc. (NASDAQ:UPB) Major Shareholder Ai Upstream Llc Buys 1,175,000 Shares

Upstream Bio, Inc. (NASDAQ:UPB) major shareholder Ai Upstream Llc acquired 1,175,000 shares of Upstream Bio stock in a transaction dated Tuesday, October 15th. The shares were acquired at an average cost of $17.00 per share, with a total value of $19,975,000.00. Following the completion of the acquisition, the insider now directly owns 1,175,000 shares in the company, valued at $19,975,000. The purchase was disclosed in a document filed with the SEC, which is accessible through this link. Major shareholders that own 10% or more of a company’s stock are required to disclose their transactions with the SEC.

Upstream Bio Price Performance

UPB stock traded down $0.03 during trading on Thursday, hitting $23.60. 420,713 shares of the stock traded hands, compared to its average volume of 479,653. Upstream Bio, Inc. has a one year low of $20.74 and a one year high of $24.35.

Upstream Bio Company Profile

Upstream Bio, Inc, a clinical-stage biotechnology company, develops treatments for inflammatory diseases that focuses on severe respiratory disorders. It develops verekitug, a monoclonal antibody that targets and inhibits the thymic stromal lymphopoietin receptor. The company also develops therapies to treat severe asthma, chronic rhinosinusitis with nasal polyps, and chronic obstructive pulmonary disease.